RUBY LEACH: Open Payments
NPI 1376637942 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 81 payments from 24 companies in 2025. Trend: 2023 $1,326 · 2024 $1,286 · 2025 $1,474
Food & beverage: $1,474
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $203 |
| AstraZeneca Pharmaceuticals LP | 8 | $191 |
| Lilly USA, LLC | 10 | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $93 |
| Amgen Inc. | 5 | $88 |
| Phathom Pharmaceuticals, Inc. | 5 | $82 |
| SANOFI-AVENTIS U.S. LLC | 3 | $75 |
| Novo Nordisk Inc | 4 | $73 |
| Gilead Sciences, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $51 |
Products named: VRAYLAR, MOUNJARO, BREZTRI, AIRSUPRA, VOQUEZNA, TZIELD, TEZSPIRE, Wegovy.
Industry payments across KY — which companies pay providers there.
